Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ureste, Maria Martín"'
Autor:
Sesé, Marta, Somoza, Rosa, Maestu, Inmaculada, Ureste, Maria Martín, Sanchez, Alfredo, Cordoba, Juan Felipe, Sansano, Irene, Venturas, Griselda, Ramón y Cajal, Santiago, Hernandez-Losa, Javier, Universitat Autònoma de Barcelona
Publikováno v:
Oncology And Therapy
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Oncology and Therapy
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Oncology and Therapy, Vol 7, Iss 2, Pp 131-139 (2019)
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Oncology and Therapy
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Oncology and Therapy, Vol 7, Iss 2, Pp 131-139 (2019)
Introduction Precision medicine has revolutionized the understanding and treatment of cancer by identifying subsets of patients who are amenable to specific treatments according to their molecular characteristics, as exemplified by epidermal growth f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a2d86d98d5ff3092890315680446d6b
https://ddd.uab.cat/record/230750
https://ddd.uab.cat/record/230750
Autor:
Sesé M; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain., Somoza R; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Maestu I; Department of Medical Oncology, Hospital Universitario Doctor Peset, Valencia, Spain., Ureste MM; Department of Medical Oncology, Hospital Universitario Doctor Peset, Valencia, Spain., Sanchez A; Department of Medical Oncology, Consorci Hospitalari Provincial de Castelló, Castellón, Spain., Cordoba JF; Department of Medical Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Sansano I; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Venturas G; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Ramón Y Cajal S; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain., Hernández-Losa J; Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain. jahernan@vhebron.net.; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. jahernan@vhebron.net.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Barcelona, Spain. jahernan@vhebron.net.
Publikováno v:
Oncology and therapy [Oncol Ther] 2019 Dec; Vol. 7 (2), pp. 131-139. Date of Electronic Publication: 2019 Aug 19.
